A regional vector-control programme against Chagas disease, launched in 1997 as the Initiative of the Central American Countries, commonly abbreviated IPCA, by Guatemala, Belize, El Salvador, Honduras, Nicaragua, Costa Rica and Panama, with the stated goals of eliminating the introduced vector Rhodnius prolixus, reducing household infestation by the native vector Triatoma dimidiata, and interrupting transmission of Trypanosoma cruzi through blood transfusion. Countries qualified for certified vector elimination once permanent surveillance showed more than three consecutive years free of vector infestation, and by this standard the Pan American Health Organization and World Health Organization had certified R. prolixus elimination in Mexico, Guatemala, Honduras, El Salvador, Nicaragua and Costa Rica by 2011, with Guatemala's own transmission interruption dated to 2008 and Honduras and Nicaragua's to 2011. Mexico joined the initiative in 2013, renaming it IPCAM, and by 2014 the combined reduction in R. prolixus and T. dimidiata infestation had significantly lowered regional Chagas incidence while blood-donor screening reached full coverage across the region.
Facts
Program StatusSuperseded; the initiative became IPCAM in 2013 after Mexico joined, following country by country achievement of vector elimination targets between 2008 and 2011. 2 Target PopulationHouseholds in vector-infested rural areas of the seven participating countries. 1 Health GoalInterrupt vector-borne transmission of Chagas disease by Rhodnius prolixus, reduce household infestation by Triatoma dimidiata, and eliminate transfusional transmission. 1 Geographic ScopeBelize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua and Panama. 1 Measured ResultsVector-borne transmission by R. prolixus was interrupted in Guatemala in 2008, and in Nicaragua and Honduras in 2010. 1 Classification
Program Kind Connections
Delivers Practice
Entity-backed identity for the program-kind enum value this public health program already carries, resolved to a health practice by an explicit value-to-entity map (phase 3 bucket conversion, docs\design_entity_backed_browse_buckets_20260928.md). The program-kind fact itself stays on the program unchanged.
In the Other Atlases
Sources
1. PAHO: Central America Conquers an Exotic Vector
Pan American Health OrganizationPAHO story page, initiative formation sentence
in 1997 three initiatives were established into one, the Initiative of the Countries of Central America and Belize
PAHO story page, participating countries list
Belize, Costa Rica, El Salvador, Guatemala, Honduras, Nicaragua, and Panama
PAHO story page, programme goals list
Interruption of Vector-borne Transmission of Chagas disease by R. prolixus, Reduction of Household Infestation by Triatoma dimidiata, and Elimination of Transfusional Transmission
PAHO story page, household infestation goal
Reduction of Household Infestation by Triatoma dimidiata
PAHO story page, country-by-country results
interruption of the transmission of the Chagas disease parasite by R. prolixus in Guatemala in 2008
Program classification, entity description sentence
A regional vector-control programme against Chagas disease, launched in 1997 as the Initiative of the Central American Countries, commonly abbreviated IPCA, by Guatemala, Belize, El Salvador, Honduras, Nicaragua, Costa Rica and Panama, with the stated goals of eliminating the introduced vector Rhodnius prolixus, reducing household infestation by the native vector Triatoma dimidiata, and interrupting transmission of Trypanosoma cruzi through blood transfusion.
View the Source 2. PMC: Subregional Initiatives for Chagas Disease
National Center for Biotechnology Information (PMC)PMC subregional initiatives review, initiative name with abbreviation
the Central American Initiative (IPCA)
PMC subregional initiatives review, IPCA to IPCAM transition
in 2013 with the accession of Mexico became IPCAM
PMC subregional initiatives review, IPCA to IPCAM transition (status)
in 2013 with the accession of Mexico became IPCAM
View the Source Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.